Research output per year
Research output per year
Personal profile
Headline
ASSOCIATE PROFESSOR Medicine, Hematology, and Medical Oncology
Biography
Fingerprint
Dive into the research topics where Yelena Ginzburg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)
Black, W. C., Abdoli, A., An, X., Auger, A., Beaulieu, P., Bernatchez, M., Caron, C., Chefson, A., Crane, S., Diallo, M., Dorich, S., Fader, L. D., Ferraro, G. B., Fournier, S., Gao, Q., Ginzburg, Y., Hamel, M., Han, Y., Jones, P. & Lanoix, S. & 17 others, , 22 Feb 2024, In: Journal of Medicinal Chemistry. 67, 4, p. 2349-2368 20 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Mitoxantrone ameliorates ineffective erythropoiesis in a β-thalassemia intermedia mouse model
Zhang, H., Liu, R., Fang, Z., Nie, L., Ma, Y., Sun, F., Mei, J., Song, Z., Ginzburg, Y. Z., Liu, J. & Chen, H., 13 Aug 2024, In: Blood advances. 8, 15, p. 4017-4024 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy
Handa, S., Sivakumar, G., Srisuwananukorn, A., Dueck, A., Tremblay, D., Mascarenhas, J. O., Ginzburg, Y., Kremyanskaya, M. & Hoffman, R., Sep 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 9, p. e314-e319Research output: Contribution to journal › Article › peer-review
-
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera
REVIVE Trial Investigators, 22 Feb 2024, In: New England Journal of Medicine. 390, 8, p. 723-735 13 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling
Sardo, U., Perrier, P., Cormier, K., Sotin, M., Personnaz, J., Medjbeur, T., Desquesnes, A., Cannizzo, L., Ruiz-Martinez, M., Thevenin, J., Billoré, B., Jung, G., Abboud, E., Peyssonnaux, C., Nemeth, E., Ginzburg, Y. Z., Ganz, T. & Kautz, L., 28 Mar 2024, In: Blood. 143, 13, p. 1282-1292 11 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Press/Media
-
A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer
Ginzburg, Y., Hoffman, R. & Kremyanskaya, M.
19/03/24
1 item of Media coverage
Press/Media
-
Novel Treatment for Polycythemia Vera Shows Promise in Clinical Trial
11/03/24
1 item of Media coverage
Press/Media
-
Novel treatment for polycythemia vera shows promise in clinical trial
Ginzburg, Y., Hoffman, R. & Kremyanskaya, M.
27/02/24
2 items of Media coverage
Press/Media
-
A "very promising" drug for polycythemia vera, the cancer suffered by Maite Galdeano, has been achieved.
22/02/24
1 item of Media coverage
Press/Media
-
News Drug Trial Shows Promise Treating Rare Blood Cancer A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debi
Ginzburg, Y., Hoffman, R. & Kremyanskaya, M.
22/02/24
2 items of Media coverage
Press/Media